S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.

MLA

Lin, Qi, et al. “S100A8 Is a Prognostic Signature and Associated with Immune Response in Diffuse Large B-Cell Lymphoma.” Frontiers in Oncology, vol. 14, Feb. 2024, p. 1344669. EBSCOhost, https://doi.org/10.3389/fonc.2024.1344669.

APA

Lin, Q., Su, J., Fang, Y., Zhong, Z., Chen, J., & Zhang, C. (2024). S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma. Frontiers in Oncology, 14, 1344669. https://doi.org/10.3389/fonc.2024.1344669

Chicago

Lin, Qi, Jianlin Su, Yuanyuan Fang, Zhihao Zhong, Jie Chen, and Chaofeng Zhang. 2024. “S100A8 Is a Prognostic Signature and Associated with Immune Response in Diffuse Large B-Cell Lymphoma.” Frontiers in Oncology 14 (February): 1344669. doi:10.3389/fonc.2024.1344669.